SCHEMBL7746323

SCHEMBL7746323

CC(C)(C)[Si](C)(C)OCCCOc1ccc(C(=O)c2ccc(OCCCO[Si](C)(C)C(C)(C)C)cc2)cc1

nearest known ligand 0.52

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 3/20 0.52
L3MBTL1 Q9Y468 4/20 0.47
GAA P10253 2/20 0.46
PPARG P37231 3/20 0.46
KMT2A Q03164 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
PLA2G4B P0C869 1/20 0.44
PPARD Q03181 1/20 0.44
LMNA P02545 2/20 0.43
MAPT P10636 2/20 0.43
MAPK1 P28482 1/20 0.43
ELANE P08246 1/20 0.42
PSMB1 P20618 1/20 0.42
PSMB5 P28074 1/20 0.42
PSMB2 P49721 1/20 0.42
TP53 P04637 1/20 0.42
TSHR P16473 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17589883 0.90 PPARA (0.60) PPARAL3MBTL1GAAPPARGPPARD
SCHEMBL5854524 0.90 PLA2G4B (0.57) L3MBTL1PLA2G4BMAPK1TP53TSHR
SCHEMBL17100201 0.89 PPARA (0.43) PPARAL3MBTL1GAAPPARGKMT2A
SCHEMBL23877854 0.88 PPARA (0.60) PPARAL3MBTL1GAAPPARGPPARD
SCHEMBL24604970 0.88 NPC1 (0.48) PPARAL3MBTL1GAAPPARGKMT2A
SCHEMBL1628037 0.87 MAPT (0.62) L3MBTL1KMT2AMAPT
SCHEMBL14648430 0.85 L3MBTL1 (0.60) L3MBTL1GAANPSR1LMNAMAPT
SCHEMBL25369942 0.83 LTA4H (0.50) LMNA
SCHEMBL17100137 0.83 PPARA (0.42) PPARAL3MBTL1GAAPPARGKMT2A
SCHEMBL19717306 0.82 MAPT (0.69) L3MBTL1GAAKMT2ALMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3473632-B1 NOVEL DIPHENYLMETHANE PROTECTIVE AGENT SEKISUI MEDICAL CO LTD (JP) 2021-10-06 EP claimed
EP-3473632-B1 NOVEL DIPHENYLMETHANE PROTECTIVE AGENT SEKISUI MEDICAL CO LTD (JP) 2021-10-06 EP disclosed
US-6262251-B1 PRODUCT ANCHORED SEQUENCIAL SYNTHESIS (PASS); AN ANCHOR GROUP ATTACHED TO THE 5' END OF THE GROWING OLIGONUCLEOTIDE PRODUCT ALLOWS THE COUPLED PRODUCT TO BE SEPARATED FROM UNREACTED STARTING MATERIALS PROLIGO LLC 2001-07-17 US disclosed
EP-0979233-A4 METHOD FOR SOLUTION PHASE SYNTHESIS OF OLIGONUCLEOTIDES PROLIGO L L C (US) 2001-03-21 EP disclosed
EP-0979233-A1 METHOD FOR SOLUTION PHASE SYNTHESIS OF OLIGONUCLEOTIDES NeXstar Pharmaceuticals, Inc. (US) 2000-02-16 EP disclosed
US-6001966-A REACTING N-TERMINAL PROTECTED AMINO ACID WITH PEPTIDE STARTING MATERIAL FORMING A PEPTIDE PRODUCT, PARTITIONING FROM UNREACTED MATERIAL AND REAGENTS BASED ON PRESENCE OF N-TERMINAL BLOCKING/ANCHORING GROUP PROLIGO LLC (US) 1999-12-14 US disclosed
US-5874532-A USING A N-TERMINAL PROTECTED AMINO ACID MONOMER NEXSTAR PHARMACEUTICALS, INC. (US) 1999-02-23 US disclosed
WO-1998047910-A1 METHOD FOR SOLUTION PHASE SYNTHESIS OF OLIGONUCLEOTIDES PROLIGO LLC (US) 1998-10-29 WO disclosed